Skip to main content

Articles

Page 2 of 9

  1. The prognosis of gastric cancer patients with a limited number of pathologically examined lymph nodes (eLN, < 16) is dismal compared to those with adequately eLN (≥ 16), yet they are still classified within th...

    Authors: Sharvesh Raj Seeruttun, Lipu Xu, Fangwei Wang, Xiaodong Yi, Cheng Fang, Zhimin Liu, Wei Wang and Zhiwei Zhou
    Citation: Cancer Communications 2019 39:32
  2. Patients in who with insufficient number of analysed lymph nodes (LNs) are more likely to receive an incorrect LN staging. The ability to calculate the overall probability of undiagnosed LN involvement errors ...

    Authors: Carlos Fortea-Sanchis, Erica Forcadell-Comes, David Martínez-Ramos and Javier Escrig-Sos
    Citation: Cancer Communications 2019 39:31
  3. A phase II clinical trial of the comparison between eribulin plus gemcitabine (EG) and paclitaxel plus gemcitabine (PG) as first-line chemotherapy for patients with metastatic breast cancer (MBC) found that th...

    Authors: Ji-Yeon Kim, Seri Park, Seock-Ah Im, Sung-Bae Kim, Joohyuk Sohn, Keun Seok Lee, Yee Soo Chae, Ki Hyeong Lee, Jee Hyun Kim, Young-Hyuck Im, Tae-Yong Kim, Kyung-Hun Lee, Jin-Hee Ahn, Gun Min Kim, In Hae Park, Soo Jung Lee…
    Citation: Cancer Communications 2019 39:29
  4. The 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) regimen is the standard first-line treatment for metastatic colorectal cancer (mCRC), however, the optimal second-line regimen for KRAS wild-type mCRC patie...

    Authors: Yuankai Shi, Jin Li, Jianming Xu, Yan Sun, Liwei Wang, Ying Cheng, Wei Liu, Guoping Sun, Yigui Chen, Li Bai, Yiping Zhang, Xiaohui He, Yi Luo, Zhehai Wang, Yunpeng Liu, Qiang Yao…
    Citation: Cancer Communications 2019 39:28
  5. Oxaliplatin, irinotecan, 5-fluorouracil, and l-leucovorin (FOLFIRINOX) has become one of the first-line treatment options for advanced pancreatic cancer (PC). However, the relatively high rate of grade 3 or 4 adv...

    Authors: Zhi-Qiang Wang, Fei Zhang, Ting Deng, Le Zhang, Fen Feng, Feng-Hua Wang, Wei Wang, De-Shen Wang, Hui-Yan Luo, Rui-Hua Xu, Yi Ba and Yu-Hong Li
    Citation: Cancer Communications 2019 39:26
  6. In the post-Z0011 trial era, the need to perform surgical axillary staging for early-stage breast cancer patients, who are treated with breast-conserving therapy (BCT), is being questioned. We conducted a retr...

    Authors: Jin Wang, Hailin Tang, Xing Li, Cailu Song, Zhenchong Xiong, Xi Wang, Xiaoming Xie and Jun Tang
    Citation: Cancer Communications 2019 39:25
  7. Tumor hypoxia is associated with metastasis and resistance to chemotherapy and radiotherapy. Genes involved in oxygen-sensing are clinically relevant and have significant implications for prognosis. In this st...

    Authors: Wai Hoong Chang, Donall Forde and Alvina G. Lai
    Citation: Cancer Communications 2019 39:23
  8. Radical cystectomy and urinary diversion remains the standard surgical treatment for patients with muscle-invasive or high-risk or recurrent non-muscle-invasive bladder cancer. Although this approach prolongs ...

    Authors: Zhiyong Li, Zhuowei Liu, Kai Yao, Zike Qin, Hui Han, Yonghong Li, Pei Dong, Yunlin Ye, Yanjun Wang, Zhiming Wu, Zhiling Zhang and Fangjian Zhou
    Citation: Cancer Communications 2019 39:19
  9. Internal tandem duplications (ITD) within the juxtamembrane domain of FMS-like tyrosine kinase 3 (FLT3) represent a poor prognostic indicator in acute myeloid leukemia (AML). Therapeutic benefits of tyrosine k...

    Authors: Xin You, Weiye Jiang, Wenhua Lu, Hui Zhang, Tiantian Yu, Jingyu Tian, Shijun Wen, Guillermo Garcia-Manero, Peng Huang and Yumin Hu
    Citation: Cancer Communications 2019 39:17
  10. The benefit of systemic treatments in esophageal squamous cell carcinoma (ESCC) which has progressed after chemotherapy is still uncertain and optimal regimens based on randomized trials have not yet been esta...

    Authors: Jing Huang, Binghe Xu, Ying Liu, Junxing Huang, Ping Lu, Yi Ba, Lin Wu, Yuxian Bai, Shu Zhang, Jifeng Feng, Ying Cheng, Jie Li, Lu Wen, Xianglin Yuan, Changwu Ma, Chunhong Hu…
    Citation: Cancer Communications 2019 39:16
  11. Currently, the diagnosis and treatment of nasopharyngeal carcinoma (NPC) patients with residual cervical lymphadenopathy following radical radiotherapy with or without chemotherapy are challenging. We investig...

    Authors: Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, Lin-Quan Tang, Qiu-Yan Chen, Huan-Xin Lin, Yu-Jing Liang, Jin-Jie Yan, Chao Lin, Shan-Shan Guo, Li-Ting Liu, Yang Li, Hao-Jun Xie, Qing-Nan Tang, Hu Liang, Ling Guo…
    Citation: Cancer Communications 2019 39:14
  12. Robust and clinically convenient biomarkers for cancer diagnosis, early detection, and prognosis have great potential to improve patient survival and are the key to precision medicine. The advent of next-gener...

    Authors: Chang Zeng, Emily Kunce Stroup, Zhou Zhang, Brian C.-H. Chiu and Wei Zhang
    Citation: Cancer Communications 2019 39:12
  13. China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment p...

    Authors: Feng-Hua Wang, Lin Shen, Jin Li, Zhi-Wei Zhou, Han Liang, Xiao-Tian Zhang, Lei Tang, Yan Xin, Jing Jin, Yu-Jing Zhang, Xiang-Lin Yuan, Tian-Shu Liu, Guo-Xin Li, Qi Wu, Hui-Mian Xu, Jia-Fu Ji…
    Citation: Cancer Communications 2019 39:10
  14. Identification of activated epidermal growth factor receptor (EGFR) mutations and application of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) have greatly changed the therapeutic strategies of non-small-cell lung ...

    Authors: Fang Wang, Xia-Yao Diao, Xiao Zhang, Qiong Shao, Yan-Fen Feng, Xin An and Hai-Yun Wang
    Citation: Cancer Communications 2019 39:7
  15. In the original publication of this article [1], the number of death cases in ‘Materials and methods’ section is incorrect.

    Authors: Jie Liu, Xu-li Yang, Si-Wei Zhang, Li-Ping Zhu and Wan-Qing Chen
    Citation: Cancer Communications 2019 39:6

    The original article was published in Cancer Communications 2018 38:75

  16. Glioblastoma (GBM) is a highly virulent tumor of the central nervous system, with a median survival < 15 months. Clearly, an improvement in treatment outcomes is needed. However, the emergence of these maligna...

    Authors: Lin Kong, Jing Gao, Jiyi Hu, Rong Lu, Jing Yang, Xianxin Qiu, Weixu Hu and Jiade J. Lu
    Citation: Cancer Communications 2019 39:5
  17. Little is known about the correlation between the clinicopathological features, postoperative treatment, and prognosis of multiple gastric cancers (MGCs). In this study, we aimed to investigate the correlation...

    Authors: Jian-Xian Lin, Zu-Kai Wang, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Ze-Ning Huang, Ju-Li Lin, Chao-Hui Zheng, Chang-Ming Huang and Ping Li
    Citation: Cancer Communications 2019 39:4
  18. In our previous study, we identified a candidate tumor suppressor gene, testin LIM domain protein (TES), in primary gastric cancer (GC). TES contains three LIM domains, which are specific interacting regions for ...

    Authors: Dan-dan Wang, Yi-bing Chen, Jing-jing Zhao, Xiao-fei Zhang, Guang-chao Zhu, De-sheng Weng, Ke Pan, Lin Lv, Qiu-zhong Pan, Shan-shan Jiang, Lei-lei Wang and Jian-chuan Xia
    Citation: Cancer Communications 2019 39:3
  19. Epithelial–mesenchymal transition (EMT) is implicated in the metastatic process and presents a challenge to epithelial cell adhesion molecule-based detection of circulating tumor cells (CTCs), which have been ...

    Authors: Xiuwen Guan, Fei Ma, Chunxiao Li, Shiyang Wu, Shangying Hu, Jiefen Huang, Xiaoying Sun, Jiayu Wang, Yang Luo, Ruigang Cai, Ying Fan, Qiao Li, Shanshan Chen, Pin Zhang, Qing Li and Binghe Xu
    Citation: Cancer Communications 2019 39:1
  20. Thus far, the incidence, mortality, and temporal trend data of oropharyngeal cancers (OPC) in China were few. We estimated the incidence, mortality, and temporal patterns of OPC in China during 2008–2012 accor...

    Authors: Jie Liu, Xu-li Yang, Si-Wei Zhang, Li-Ping Zhu and Wan-Qing Chen
    Citation: Cancer Communications 2018 38:75

    The Correction to this article has been published in Cancer Communications 2019 39:6

  21. Postradiation nasopharyngeal necrosis (PRNN) is a severe complication after radiotherapy in patients with nasopharyngeal carcinoma (NPC), which can severely affect the quality of life and threaten the patient’...

    Authors: Xiong Zou, Shun-Lan Wang, You-Ping Liu, Yan-Ling Liu, Ru-Hai Zou, Yi-Nuan Zhang, Rui You, Qi Yang, Yu-Long Xie, Mei Lin, Pei-Yu Huang, Rou Jiang, Meng-Xia Zhang, Chao-Nan Qian, Hai-Qiang Mai, Ling Guo…
    Citation: Cancer Communications 2018 38:74
  22. The preliminary results of our phase II randomized trial reported comparable functional sphincter preservation rates and short-term survival outcomes between patients undergoing total mesorectal excision (TME)...

    Authors: Fulong Wang, Wenhua Fan, Jianhong Peng, Zhenhai Lu, Zhizhong Pan, Liren Li, Yuanhong Gao, Hui Li, Gong Chen, Xiaojun Wu, Peirong Ding, Zhifan Zeng and Desen Wan
    Citation: Cancer Communications 2018 38:73
  23. An increasing number of cancer patients die of cardiovascular diseases. The cardiotoxicity of chemotherapy is particularly important in triple-negative breast cancer (TNBC) with limited therapeutic options. Ca...

    Authors: Binliang Liu, Tao An, Meiying Li, Zongbi Yi, Chunxiao Li, Xiaoying Sun, Xiuwen Guan, Lixi Li, Yanfeng Wang, Yuhui Zhang, Binghe Xu, Fei Ma and Yixin Zeng
    Citation: Cancer Communications 2018 38:71
  24. Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive, and poorly investigated simple sarcoma with a low frequency of genetic deregulation other than an Ewing sarcoma RNA binding protein 1 (EWSR1)-Wil...

    Authors: Andrea Devecchi, Loris De Cecco, Matteo Dugo, Donata Penso, Gianpaolo Dagrada, Silvia Brich, Silvia Stacchiotti, Marialuisa Sensi, Silvana Canevari and Silvana Pilotti
    Citation: Cancer Communications 2018 38:70
  25. The 8th American Joint Committee on Cancer tumor–node–metastasis (AJCC-TNM) staging system is based on a few retrospective single-center studies. We aimed to test the prognostic validity of the staging system ...

    Authors: Zai-Shang Li, Antonio Augusto Ornellas, Christian Schwentner, Xiang Li, Alcides Chaux, Georges Netto, Arthur L. Burnett, Yong Tang, JiunHung Geng, Kai Yao, Xiao-Feng Chen, Bin Wang, Hong Liao, Nan Liu, Peng Chen, Yong-Hong Lei…
    Citation: Cancer Communications 2018 38:68
  26. The 8th edition of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) pathological tumor-node-metastasis (pTNM) staging system may have increased accuracy in predicting p...

    Authors: Cheng Fang, Wei Wang, Jing-Yu Deng, Zhe Sun, Sharvesh Raj Seeruttun, Zhen-Ning Wang, Hui-Mian Xu, Han Liang and Zhi-Wei Zhou
    Citation: Cancer Communications 2018 38:67
  27. Famitinib is a tyrosine kinase inhibitor against multiple targets, including vascular endothelial growth factor receptor 2/3, platelet-derived growth factor receptor, and stem cell factor receptor (c-kit). Pre...

    Authors: Qiuyan Chen, Linquan Tang, Na Liu, Feng Han, Ling Guo, Shanshan Guo, Jianwei Wang, Huai Liu, Yanfang Ye, Lu Zhang, Liting Liu, Pan Wang, Yingqin Li, Qingmei He, Xiaoqun Yang, Qingnan Tang…
    Citation: Cancer Communications 2018 38:66
  28. Cancer cells uniquely reprogram their cellular activities to support their rapid proliferation and migration and to counteract metabolic and genotoxic stress during cancer progression. In this reprograming, ca...

    Authors: Yugang Wang, Yan Xia and Zhimin Lu
    Citation: Cancer Communications 2018 38:65
  29. Recent studies highlight pseudogene derived long non-coding RNAs (lncRNAs) as key regulators of cancer biology. However, few of them have been well characterized in pancreatic cancer. Here, we aimed to identif...

    Authors: Yifan Lian, Jiebin Yang, Yikai Lian, Chuangxing Xiao, Xuezhen Hu and Hongzhi Xu
    Citation: Cancer Communications 2018 38:64
  30. Natural killer/T-cell lymphoma (NKTCL) is a highly aggressive non-Hodgkin lymphoma often resistant to chemotherapy. Serum level of soluble IL-2 receptor α (IL-2Rα) is elevated in NKTCL patients and correlates ...

    Authors: Liang Wang, Xi-wen Bi, Yu-jia Zhu, Ying-zhi He, Qiu-yu Lai, Zhong-jun Xia and Qing-qing Cai
    Citation: Cancer Communications 2018 38:62
  31. The optimal strategy for adjuvant therapy after curative resection for hepatocellular carcinoma (HCC) patients with solitary tumor and microvascular invasion (MVI) is controversial. This trial evaluated the ef...

    Authors: Wei Wei, Pei-En Jian, Shao-Hua Li, Zhi-Xing Guo, Yong-Fa Zhang, Yi-Hong Ling, Xiao-Jun Lin, Li Xu, Ming Shi, Lie Zheng, Min-Shan Chen and Rong-Ping Guo
    Citation: Cancer Communications 2018 38:61
  32. Patient-derived organoids and xenografts (PDXs) have emerged as powerful models in functional diagnostics with high predictive power for anticancer drug response. However, limitations such as engraftment failu...

    Authors: Feifei Zhang, Wenjie Wang, Yuan Long, Hui Liu, Jijun Cheng, Lin Guo, Rongyu Li, Chao Meng, Shan Yu, Qingchuan Zhao, Shun Lu, Lili Wang, Haitao Wang and Danyi Wen
    Citation: Cancer Communications 2018 38:60
  33. Due to the occult anatomic location of the nasopharynx and frequent presence of adenoid hyperplasia, the positive rate for malignancy identification during biopsy is low, thus leading to delayed or missed diag...

    Authors: Chaofeng Li, Bingzhong Jing, Liangru Ke, Bin Li, Weixiong Xia, Caisheng He, Chaonan Qian, Chong Zhao, Haiqiang Mai, Mingyuan Chen, Kajia Cao, Haoyuan Mo, Ling Guo, Qiuyan Chen, Linquan Tang, Wenze Qiu…
    Citation: Cancer Communications 2018 38:59